Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Pharmacokinetics of intravenous and oral prednisolone.

Al-Habet S, Rogers HJ.

Br J Clin Pharmacol. 1980 Nov;10(5):503-8.

2.

The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration.

Täuber U, Haack D, Nieuweboer B, Kloss G, Vecsei P, Wendt H.

Int J Clin Pharmacol Ther Toxicol. 1984 Jan;22(1):48-55.

PMID:
6698661
3.

Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.

Persiani S, D'Amato M, Makovec F, Tavares IA, Bishai PM, Rovati LC.

Int J Clin Pharmacol Ther. 2002 May;40(5):198-206.

PMID:
12051571
4.

Urinary excretion of prednisolone following intravenous administration in humans.

al-Habet SM, Rogers HJ.

J Clin Pharmacol. 1989 Oct;29(10):922-7.

PMID:
2592584
5.
6.

Intravenous pharmacokinetics and absolute oral bioavailability of dolasetron in healthy volunteers: part 1.

Dimmitt DC, Choo YS, Martin LA, Arumugham T, Hahne WF, Weir SJ.

Biopharm Drug Dispos. 1999 Jan;20(1):29-39.

PMID:
10086835
7.

Methylprednisolone pharmacokinetics after intravenous and oral administration.

Al-Habet SM, Rogers HJ.

Br J Clin Pharmacol. 1989 Mar;27(3):285-90.

8.

Pharmacokinetics of prednisolone after high doses of prednisolone hemisuccinate.

Derendorf H, Rohdewald P, Möllmann H, Rehder J, Barth J, Neveling D.

Biopharm Drug Dispos. 1985 Oct-Dec;6(4):423-32.

PMID:
4084667
9.

Alterations in prednisolone disposition as a result of oral contraceptive use and dose.

Meffin PJ, Wing LM, Sallustio BC, Brooks PM.

Br J Clin Pharmacol. 1984 Jun;17(6):655-64.

10.

Pharmacokinetics of the triazole antifungal agent genaconazole in healthy men after oral and intravenous administration.

Mojaverian P, Radwanski E, Affrime MB, Cayen MN, Lin CC.

Antimicrob Agents Chemother. 1994 Dec;38(12):2758-62.

11.

Pharmacokinetics of methylprednisolone and prednisolone after single and multiple oral administration.

Rohatagi S, Barth J, Möllmann H, Hochhaus G, Soldner A, Möllmann C, Derendorf H.

J Clin Pharmacol. 1997 Oct;37(10):916-25.

PMID:
9505983
12.

Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent.

Aneja R, Dhiman N, Idnani J, Awasthi A, Arora SK, Chandra R, Joshi HC.

Cancer Chemother Pharmacol. 2007 Nov;60(6):831-9. Epub 2007 Feb 7.

PMID:
17285314
13.

Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.

Petersen KB, Jusko WJ, Rasmussen M, Schmiegelow K.

Cancer Chemother Pharmacol. 2003 Jun;51(6):465-73. Epub 2003 Apr 16.

PMID:
12698270
14.

Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.

Jagannath K, Chaluvadi MR, Mullangi R, Mamidi NV, Srinivas NR.

Biopharm Drug Dispos. 2004 Oct;25(7):323-8.

PMID:
15386480
15.

Pharmacokinetics of selamectin following intravenous, oral and topical administration in cats and dogs.

Sarasola P, Jernigan AD, Walker DK, Castledine J, Smith DG, Rowan TG.

J Vet Pharmacol Ther. 2002 Aug;25(4):265-72.

PMID:
12213114
16.

Pharmacokinetics and pharmacodynamics of prednisolone after intravenous and oral administration.

Barth J, Damoiseaux M, Möllmann H, Brandis KH, Hochhaus G, Derendorf H.

Int J Clin Pharmacol Ther Toxicol. 1992 Sep;30(9):317-24.

PMID:
1428295
17.
18.

Amantadine and equine influenza: pharmacology, pharmacokinetics and neurological effects in the horse.

Rees WA, Harkins JD, Woods WE, Blouin RA, Lu M, Fenger C, Holland RE, Chambers TM, Tobin T.

Equine Vet J. 1997 Mar;29(2):104-10.

PMID:
9104558
19.

Relative and absolute bioavailability of prednisone and prednisolone after separate oral and intravenous doses.

Ferry JJ, Horvath AM, Bekersky I, Heath EC, Ryan CF, Colburn WA.

J Clin Pharmacol. 1988 Jan;28(1):81-7.

PMID:
3350994
20.

The absence of effect of azathioprine on prednisolone pharmacokinetics following maintenance prednisone doses in kidney transplant patients.

Gambertoglio JG, Holford HG, Lizak PS, Birnbaum JL, Salvatierra O Jr, Amend WJ Jr.

Am J Kidney Dis. 1984 May;3(6):425-9.

PMID:
6372445

Supplemental Content

Support Center